Cartesian Therapeutics, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Cartesian Therapeutics, Inc. (RNAC) had Convertible Preferred Stock, Shares Issued upon Conversion of 1 shares as of 2024-07-02, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures › Features of Convertible Preferred Stock
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2026-03-09
- 2024-07-02: Convertible Preferred Stock, Shares Issued upon Conversion 1.00 shares.
- 2016-06-27: Convertible Preferred Stock, Shares Issued upon Conversion 10.13M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2024-07-02 | 1.00 shares 10-K · filed 2026-03-09 |
| 2016-06-27 | 10.13M shares 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |